Drug profile · INN
anisotropine methylbromide
ANISOTROPINE METHYLBROMIDE
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
anisotropine methylbromide (ANISOTROPINE METHYLBROMIDE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN anisotropine methylbromide
Brand ANISOTROPINE METHYLBROMIDE
Route ORAL
Formulation TABLET
Frequently asked questions
What is anisotropine methylbromide?
anisotropine methylbromide (ANISOTROPINE METHYLBROMIDE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for anisotropine methylbromide?
ANISOTROPINE METHYLBROMIDE is a marketed brand name for anisotropine methylbromide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of anisotropine methylbromide?
anisotropine methylbromide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.